Thyroid Cancer Drugs Global Market Estimated To Grow At 17% Rate
September 23, 2022
The Business Research Company’s Thyroid Cancer Drugs Global Market Report 2022: Market Size, Trends, And Forecast To 2026
LONDON, GREATER LONDON, UK, September 23, 2022 /EINPresswire.com/ -- As per The Business Research Company's "Thyroid Cancer Drugs Global Market Report 2022”, the thyroid cancer drugs market is expected to grow from $0.61 billion in 2021 to $0.72 billion in 2022 at a compound annual growth rate (CAGR) of 18.6%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global thyroid cancer drug market size is expected to reach $1.33 billion in 2026 at a CAGR of 16.7%. Increasing incidences of thyroid cancer, especially in women is driving the thyroid cancer drugs market.
Request a Sample now to gain a better understanding of thyroid cancer drugs market:
Key Trends In The Thyroid Cancer Drugs Market
Combination drugs are increasingly being used in the treatment of thyroid cancer as they are more effective and help prevent cancer progression. A combination drug includes two or more active pharmaceutical ingredients (APIs) combined in a single dosage form. These drugs reduce the development of drug resistance and prevent the growth of cancer cells.
Overview Of The Thyroid Cancer Drugs Market
The thyroid cancer drugs market consists of sales of drugs that are used to treat thyroid cancer. The thyroid tissue is made up of follicular cells and parafollicular cells in which cancer develops. The types of thyroid cancer include follicular, papillary, medullary, anaplastic and thyroid lymphoma.
Learn more on the global thyroid cancer drugs market report at:
Thyroid Cancer Drugs Global Market Report 2022 from TBRC covers the following information:
Market Size Data
• Forecast period: Historical and Future
• By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• By countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
• By Drug Type: Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Others
• By End-User: Hospitals, Oncology Clinics, Research Organizations, Others
• By Type: Radioiodine Ablation, Thyroid Stimulating Hormone (THS) Suppression, Chemotherapy, Targeted Multikinase Therapy, Others
• By Geography: The global thyroid cancer drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America holds the largest share in the market.
Major market players such as Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva Parenteral Medicines Inc., Jerome Stevens Pharmaceuticals Inc., Baxter International Inc., Abbott Laboratories, App Pharmaceuticals llc., AstraZeneca PLC and GlaxoSmithKline plc.
Trends, opportunities, strategies and so much more.
Thyroid Cancer Drugs Global Market Report 2022 is one of The Business Research Company’s comprehensive reports that provides an overview of thyroid cancer drugs market. The market report analyzes thyroid cancer drugs global market size, thyroid cancer drugs market share, thyroid cancer drugs global market growth drivers, thyroid cancer drugs global market segments, thyroid cancer drugs market major players, thyroid cancer drugs global market growth across geographies, thyroid cancer drugs global market trends and thyroid cancer drugs market competitors’ revenues and market positioning. The thyroid cancer drugs market report enables you to gain insights on opportunities and strategies, as well as identify countries and segments with the highest growth potential.
Not what you were looking for? Go through similar reports by The Business Research Company:
Oncology Devices Global Market Report 2022
Oncology Molecular Diagnostics Global Market Report 2022
Oncology Drugs Global Market Report 2022
About The Business Research Company?
The Business Research Company has published over 3000 industry reports, covering over 3000 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Check out our:
TBRC Blog: http://blog.tbrc.info/
Market Research Products, Services, Solutions For Your Business - TBRC